H. Hausmaninger

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

Monika Schindl, Sebastian F. Schoppmann, Hellmut Samonigg et al. · PubMed · 2002 · 387 citations

Medicine, Cancer Biology, Oncology +15

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

Michael Gnant, Brigitte Mlineritsch, G. Luschin-Ebengreuth et al. · Journal of Clinical Oncology · 2006 · 330 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5

R. Jakesz, H. Hausmaninger, E. Kubista et al. · Journal of Clinical Oncology · 2002 · 288 citations

Medicine, Oncology, Pharmacology +17

Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer

Sebastian F. Schoppmann, Guenther Bayer, Klaus Aumayr et al. · Annals of Surgery · 2004 · 277 citations · Full text

Medicine, Oncology, Pathology +17

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

Gudrun Windbichler, H. Hausmaninger, W. Stummvoll et al. · British Journal of Cancer · 2000 · 245 citations · Full text

Medicine, Oncology, Surgery +8